Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

Navigator Medicines, Inc., a clinical-stage biotech company leading the advancement of biologics for targeted immune regulation and restoration, today announced the appointments of Tausif (?Tosh') ...

The decision to take both treatment arms forward suggests there may be an efficacy signal for the TIM-3 drug, which was acquired by GSK when it took over Tesaro in a $5.1 billion deal agreed in ...

GSK meanwhile has previously suggest that the HBV therapy could collectively achieve sales of more than £2 billion ($2.45 billion) at peak, part of a new wave of therapies that it reckons could ...

New research shows that a network of subcellular structures similar to those responsible for propagating molecular signals that make muscles contract are also responsible for transmitting signals in ...

Filled with the top stories to start your day, and emergency news alerts.

Teva Pharmaceutical Industries Ltd. ADR-1.51% $18.8B ...

The equity income funds that have ticked all the boxes since 2022 ...

The Signal is produced by senior students at the University of King’s College School of Journalism, Writing & Publishing.